The facial plastic surgeon, Dr. Steven Dayan, shares how research on beauty, mood and social connection reported the development of Xomd Skin, a new line of care of the Moodceutical skin co-created with dermatologist Dr. Sabrina Fabi.
In the increasingly saturated skin care market, creating a line of products that resonates with clinical rigor and emotional intelligence is not a small feat. But for the Steven Dayan Facial Plastic Surgeon, MD, FACS, and its partner in life and business, the dermatologist certified by the Board Sabrina Fabi, MD, the motivation behind Xomd Skin was not just to develop another cosmeteutical-it was the Aererererererererererer Aererer Aerer Aererrer Aererer Aerer Aerer Aerer Aerer Aererer Aerer Aererer Aerer Aererer Aererer Aererer Aererer Aerer Aerer Aerer Aerer Aerer Aerer Aereer Aereer Aerer Aereer Aereer Aereer Aereer Aereer AERER AERER AERER AERER AERERRE AERERRER AERERER AERERER AERERER AERER AERER AERER AERER AERER AERER AERRERERERERERERERERERERRERTERYUTICALUTICAL-IT.
In this interview with Practice of Plastic SurgeryDayan analyzes how decades of research on the science of beauty and the human connection led to the creation of Xomd, a line of clinical validated skin designed to influence not only how the skin looks, but also how people feel and interact. Developed in collaboration with Fabi, the line introduces the concept of “moodceuticals”, topical fortments aimed at improving both dermal health and psychosocial well -being.
Practice of Plastic Surgery: What inspired him to create Xomd skin and how his experience as a plastic surgeon in practice influenced brand development?
Steven Dayan, MD, FACS: From the beginning of my career, I have believed that aesthetics should be less about how you look, and more about how you feel. That approach change changed everything to me as a doctor. At first, I realized that my patients maintain persecution symmetry or surface perfection; They wanted to feel safe, connected and more like them again. That idea led me to immerse myself deeply in the science of beauty, attraction and psychosocial impact of aesthetic treatments.
I spent two decades investigating thesis issues, ultimately publishing in 200 medical articles and writing The New York Times Better sold Exposed subliminally. I developed and taught a university course in Depaul on the science of beauty and its cultural and commercial implies. All this built the foundations for what would become Xomd skin.
At the years, I had many sacrifices to put my name in a skin care line. But private labeling never felt authentic. I was interested in slapping my credentials in another person’s formula. If I was going to create something, I had embodied the philosophies to which I have dedicated my career, and it had to be new, different and truly shocking.
When Sabrina and I became partners in life and work, everything accelerated. She contributed her experience in skin health and clinical dermatology; I brought the science of attraction and psychosocial well -being. Together, our conversations (including a lot of pillow talks) became philosophical, or circled oxytocin, the so -called “love hormone”, which fascinated us both for emisiological and physiological ITE.
It was the time for her pregnancy, literally looking at her, that we had our ‘Eureka’ moment. Oxytocin was just a hormone feeling good, visible it changed the skin. That information launched us on a research, formulation and tests of several years. We look for a botanical solution that could imitate the effects of oxytocin, and we find it.
But we did not stop in inspiration, we demanded evidence. We draw our formulation through a randomized and double -blind cross essay, controlled with placebo, one of the most rigorous methods of science. Almost 3 years later, Xomd was born: a validated and emotionally intelligent clinical line that reflects around 100,000 patient meetings, more than 400 scientific publications and decades of combined experience.
It has an important leg for us to send a message that, although we are inspired, Xomd does not contain oxytocin. As doctors, we must be clear that Xomd products are not intended to diagnose, treat, cure or prevention of any disease. And we always suggest consulting a health professional if there is any underlying concerns or conditions.
PSP: Today there is no shortage of skin care lines. What gaps in the market was aimed at addressing with Xomd Skin?
Dayan: Most skin care lines focus on biochemical or cellular benefits: Collegen production, elastin synthesis, inflammation reduction. That is important, but does not tell the complete story. Patients do not enter our offices asking for thicker dermis. They want to feel beautiful. They want confidence. They want them to notice.
With Xomd, we take the reverse approach. We ask: Why do people see aesthetic treatments first? Then we work back from that emotional motivation. Yes, our formula improves skin quality, but our true objective was to develop the first line of skin care with pro-social benefits, so it could not only appear, but of humor, self-perception and social connection.
We are not just another cosmeceutical. We coined the term Moodceutical tOr describe what we believe is the next border in skin care: products that influence how you feel, how they perceive you and how you interact with the world.
PSP: then, Xomd’s skin is marketed as a Bad mood. What does that mean and how do you reflect science behind your brand?
Dayan: TO Bad mood It is skin care that works on more than the surface. We design Xomd to improve mood, improve perceived attractiveness and foster positive social interactions. To demonstrate that we carry out a double blind study, controlled with placebo and randomized, something rarely done in the world of skin care.
Yes, we validate improvements in skin radiation, tone, hydration and redness. But we also measure the psychosocial results: perceived trust, first impressions, self -evaluated attractive and equally sexual satisfaction, which surpasses both users and their partners. The results? Statistically significant in all areas. He even exceeded our expectations.
You can find the complete clinical data in our published study: Fabi SG, Dayan SH, Goldie K, et al. Unlocking of the psycho-social-dermal axis: a double-blind randomized study of the life of life of life and sexual satisfaction. J Cosmatol Dermatol. 2024; 23 (9): 2905-2917.
PSP: Can you give us an overview of the XOMD product line and how does it work?
Dayan: The XOMD formula is based on three proprietary pillars: phospholipids, a botanist derived from jasmine and an alatal extract. Together, these ingredients work synergily to address the social axis of the skin – brain -.
- Phospholipids Strengthen skin barrier and reduce inflammation.
- Jasmine derivatives It is known that they stimulate the mechanoreceptors of the skin and mimic hydration, calm and radiation that promote the effects similar to oxytocin.
- Eaves -derived isobutyric acidA compound that is also found in natural copulinas, has known feromonal properties and contributes to greater privacy and attraction.
These ingredients pass through multiple refinement rounds approximately 2 years before we satisfy ourselves. And we did not stop there: we validated the formula in a rigorous clinical trial. This is not just another product for luxury skin care; It is a completely new category.
PSP: Who is the ideal consumer for Xomd skin?
Dayan: Any person with normal to sensitive skin that is their skin, and their energy, to shine. It is for the woman (or man) that is tired of empty promises and moves something that real offers not only how they look, but how they feel and how others respond to them. If you are looking for that additional spark, the child who touches your head, Xomd was made for you.
PSP: How do you balance a practice and launch a brand?
Dayan: I don’t sleep much more! But I am both passionate about. My clinical work feeds my curiosity. The brand gives me a creative and scientific exit. I am lucky to work with Sabrina, who is equally motivated. When you are deeply excited about what you are building, it does not feel like work. It feels like a purpose.
PSP: What follows for the products, research or global expansion of Xomd?
Dayan: We are receiving an incredible response: invoice only from dermatologists and aesthetic doctors, but also from the communities of welfare and sexual health. Some have called it the greatest advance in skin care from retinol. That is a bold statement, but we will take it!
We are already in conversations with distributors in Europe, Western Asia and Canada, and we are expanding our presence of the USA. In clinics, medspas and direct to the consumer.
But we are not stopping there. Recently we organized a quick appointment event in which half of the participants used Xomd and half did not, just to explore social effects on real life. We have just created custom conversation cards to help cause deeper and more secure interactions. That son of prosocial dissemination is where we see the future: care of skin care, that is not just about looking good, but also living better. Ulemately, we are here to lead a movement. One in which skin care raises not only beauty, but the connection, the car -vorth and joy. PSP
